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Abstract
Objective: Lumbar arthrodesis is a common surgical technique that consists of the fixation of one or more motion
segments with pedicle screws and rods. However, spinal surgery using these techniques is expensive and has a
significant impact on the budgets of hospitals and Healthcare Systems. While reusable and disposable instruments
for laparoscopic interventions have been studied in literature, no specific information exists regarding instrument
kits for lumbar arthrodesis. The aim of the present study was to perform a complete health technology assessment
comparing a disposable instrument kit for lumbar arthrodesis (innovative device) with the standard reusable instrument.
Methods: A prospective and observational study was implemented, by means of investigation of administrative
records of patients undergoing a lumbar arthrodesis surgical procedure. The evaluation was conducted in 2013,
over a 12- month time horizon, considering all the procedures carried out using the two technologies. A complete
health technology assessment and a multi-criteria decision analysis approach were implemented in order to
compare the two alternative technologies. Economic impact (with the implementation of an activity based
costing approach), social, ethical, organisational, and technology-related aspects were taken into account.
Results: Although the cost analysis produced similar results in the comparison of the two technologies (total cost
equal to € 4,279.1 and € 4,242.6 for reusable instrument kit and the disposable one respectively), a significant
difference between the two instrument kits was noted, in particular concerning the organisational impact and
the patient safety.
Conclusions: The replacement of a reusable instrument kit for lumbar arthrodesis, with a disposable one, could
improve the management of this kind of devices in hospital settings.
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Background
Governments of developed countries, particularly in the
western part of the World, have found it difficult to in-
crease healthcare expenditure over the gross domestic
product. Economic crises and the need to cut budgets
have become more and more a priority on the policy
makers agendas. This complex situation has been severe
in Italy, where spending review austerity has been re-
quired, and strictly monitored by the Government [1].
As result, the provision, implementation and diffusion of
expensive technology and organisational-based innovation
[2] has been difficult and, often, limited. In this view, the
technologies used in spinal surgery could be considered as
part of the high-resource consumption innovations, consid-
ering both innovative techniques and consolidated inter-
ventions, such as spinal arthrodesis (the fixation of one or
more spinal levels by means of pedicle screws and rods), as-
suming the Healthcare System or hospital point of view [3].
At institutional level in general, and in particular at hospital
level, professionals and decision makers have introduced
new devices, instruments and, in general, technologies only
when they are able to demonstrate their value for money,
in terms of technical advantages, effectiveness, equity and
organisational aspects. Moving on from these premises,
hospital clinicians and decision makers, as well as regional
and national institutions could therefore adopt tools that
are useful to assess the technologies-related evidence, for a
better decision making process [4].
In this regard, several cost-effectiveness and cost-utility
analyses have been conducted over the last 20 years, in
Europe, with the aim of choosing the best treatment
options for patients, without losing important financial
resources [5, 6]. Health Technology Assessment (HTA)
is a multi-dimensional and systematic approach useful
to analyse different technologies, examining their eco-
nomic, social, clinical, ethical and organisational implica-
tions [7]. The main objective of an HTA analysis is usually
to create an evidence-based support for policy makers,
optimising thus citizens’ health.
Reusable and disposable surgical instruments have
been studied from a cost-effectiveness point of view, par-
ticularly with regard to laparoscopic surgical techniques:
reusable instruments were found to be less expensive, en-
suring the same performances in terms of safety and ef-
fectiveness [8, 9].
However, to the best of the authors’ knowledge, no
studies have been focused on instrument kits in the
specific setting of lumbar arthrodesis, with a complete
multidimensional assessment approach. Therefore, the
aim of the present study was to perform an HTA evalu-
ation, focusing on two pedicle screws instrument kits used
for short lumbar arthrodesis: in particular, an innovative
disposable kit was compared with a traditional reusable
one, with the development of a final multi-criteria decision
analysis [10], thus being consistent with the EUnetHTA
Core Model approach [11], EVIDEM suggestions [10] and
Lombardy Region HTA practices [1].
Methods
A Health Technology Assessment (HTA) approach was
implemented, in order to achieve the primary objective
of the study.
In particular, the HTA study was performed within a
Spinal Surgery Unit of the “IRCCS Istituto Ortopedico
Galeazzi” hospital of Milan. The standard reusable in-
strument kit used to perform a spinal stabilization by
means of pedicle screws, was compared with the dis-
posable device Steri Spine PS (Safe Orthopaedic SAS,
Eragny-sur-Oise, France).
A prospective and observational study was implemented.
The evaluation was conducted in 2013, over a 12 month
time horizon, considering all the procedures carried out
using both the technologies under investigation, by three
experienced spinal surgeons.
Because of the multi-dimensional and multi-disciplinary
nature of HTA, this approach considered several aspects
of the medical technologies, as required by the EUnetHTA
Core Model, 2016 [11]. In particular, the following dimen-
sions were analysed (Table 1): i) general relevance; ii)
safety; iii) efficacy and effectiveness; iv) economic and fi-
nancial impact; v) equity; vi) legal aspects; vii) social and
ethical impact; and viii) organisational impact. After the
assessment of all the dimensions, a Multi-Criteria Deci-
sion Analysis (MCDA) approach [10] was implemented,
thus defining the appraisal phase. First, as required by
Lombardy Region HTA practise [1], the dimensions were
prioritised, using a rating scale ranging from 1 (more
important dimension) to 8 (least important dimension).
Second, a three level rating score of 1 (less performant),
2 (equal performant) or 3 (more performant) was applied,
by five expert evaluators, to each variable investigated,
leading to a final concise result useful for the choice of the
“preferable” technology.
A group, composed of three experienced surgeons
using the investigated technologies and two individuals
referring to the clinical management of the hospital of




The literature review revealed a lack of randomised con-
trolled trials related to this topic, and also an absence of
HTA reports and studies focusing on the comparison of
the two instrument kits in the present study. In this
view, only 2 papers (out of more than 25 evidence found,
using the keywords “surgical disposable kit” and/or
“HTA” and/or “spinal surgery”) met the research criteria,
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since the others were considered not focused on the effi-
cacy or safety information, on the comparative analysis,
out-of-scope for the evaluation or concerning other clinical
specialties and not spinal surgery.
The debate concerning the use of reusable or disposable
devices in the clinical practice is still open: in some cases,
(e.g. laparoscopic interventions) it has been demonstrated
that reusable instruments reduce the costs of the surgical
treatments [8, 9] while disposable devices have been
shown to have a positive influence on the hospital
management, being easier to handle, to stock and not
requiring a sterilization.
It emerged from the review that lumbar arthrodesis is
a common surgical technique used to treat traumatic or
degenerative pathologies and may be potentially performed
on a large set of patients. The technologies involved in the
HTA study were similar, in terms of the treatment indi-
cations and patients involved. Potential benefits of a
disposable instrument kit are the reduction of the pre/
post-operative costs due to the sterilization, the reduction
Table 1 Methods used for the assessment of each dimension
Dimension Method
General relevance An in-depth literature review [14] was carried out, adapting the results obtained for the practices observed
within the specific hospital involved in the study. The quality of scientific evidence and the agreement
with the hospital policies were examined. This dimension required a description of the technology and
the pathology under assessment and, in addition, the definition of the real and potential catchment area of
reference for the procedures.
In this view, evidence was retrieved using both Pubmed and Cochrane Databases, including the following
keywords: “HTA assessment”, “surgical disposable devices”, “surgical instrument kit”. In particular, the literature
review considered the following PICO: P (patients undergoing spinal surgical procedure), I (surgical disposable
instrument kit), C (surgical reusable instrument kit), O (outcome related to the development of adverse events,
economic data and clinical effectiveness).
Safety The safety of patients (in terms of evaluation of adverse events, mortality or morbidity related to the technologies
under assessment) and of healthcare professionals, as well as the environmental impact related to the use of the
different technologies, was investigated using a 5-level Likert scale, ranging from a minimum of 1 (worst impact)
to a maximum of 5 (best impact).
Efficacy and effectiveness Since no comparative parameters of efficacy were found in the literature review, a qualitative indicator was
collected from the real world evidence by means of a survey, directed at the experienced surgeons of the
Clinical Institute performing these surgical procedures. This methodological approach was consistent with
the literature of reference in the case of an absence of specific metrics and indicators [15]. The perceived
effectiveness declared by the surgeons, using a 5-level scale ranging from a minimum of 1 (least performant),
to a maximum of 5 (most performant), was retrieved, considering the ease of kit opening, the traceability,
the comfort in use and the ease of identification of the product.
Economic and financial impact
(assuming the hospital perspective)
• Activity Based Costing (ABC) analysis [16, 17]: an analysis that led to the identification, quantification, and
consequent evaluation of resources required for a single clinical process, with the evaluation of all the direct
costs (considering human resources, laboratory services, consumer products, and drugs, as well as sterilisation
processes) related to each technology. In this view, the duration of each procedure and the level of the
instrumentation, as well as the number of x-rays performed, were calculated in order to have a preliminary
idea of the impact of the surgical procedure. Data regarding the pre-operative processes (order preparation
time, supply time, storage area occupied, time, and cost of sterilisation) and intra-operative data (kit unpacking
time, instrument preparation, and surgeons’ perceptions) were acquired. Here, it should be noted that all the
information used for the proper economic assessment was directly retrieved from the hospital involved in the
analysis. These aspects of expenditure were evaluated considering the 2014 Lombardy Region’s outpatients
and hospital admission reimbursement tariff and drug costs, derived from the official NHS price list.
• Cost-effectiveness analysis (CEA): an analysis correlated the above mentioned process costs (derived from the ABC)
with the effectiveness data.
• Budget Impact Analysis (BIA) [13]: a baseline scenario (historical) consisting only of patients undergoing the
standard procedure (i.e. the reusable device) compared with an innovative scenario composed of the
introduction and the implementation of the innovative technology.
Equity aspects The health professionals involved in the study rated their perceptions, using a 7-item Likert scale, with regard to
the accessibility, rapidity, usability, and invasiveness of the alternative technologies, as well as the access to care
for persons of a legally protected status.
Legal impact Both the indications of use for all the surgical procedures, categories of patients, and presence of authorization
of use at national, European and International levels were evaluated using a 7-item Likert scale.
Ethical and social dimension Usinging a 7-item Likert scale, the professionals involved evaluated the acceptability of the technologies
under investigation, the impact of the technologies on the patient’s life style, the productivity losses impact,
and the environmental impact and the impact of the procedure on the care giver’s life and perceptions.
Organisational impact The organisational impact was evaluated using both a qualitative and a quantitative approach. From a quantitative
perspective, all the additional investments required for the proper implementation of the technologies, as well as
the impact of the innovative technology on the hospital processes, were investigated. From a qualitative point of
view, the following items were assessed, considering the professionals’ perceptions: additional staff, training course,
meetings and communication, learning curve, and equipment/furniture purchase or update.
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of the risk of contamination, total traceability and new
instruments for each surgery thus reducing the risk of
damaged devices.
Focusing on the specific setting where the analysis was
conducted, results showed that out of the 1,500 spinal
surgeries performed every year, 139 were patients undergo-
ing lumbar arthrodesis, thus revealing its importance (9%).
Safety and effectiveness
The standard reusable technology is associated with a
higher level of safety, even if the disposable instrument
kits is advantageous for guaranteeing the safety of both
healthcare professionals and patients. In quantifying the
difference between the technologies, the standard one
achieved a higher average value of perception when com-
pared with the innovative one, even if the difference was
not statistically significant (3.99 vs 3.70, p-value = 0.198).
With regard to effectiveness, the professionals involved
in the analysis declared a final average score of 4.13 for
the innovative kit compared with 3.56 for the reusable
one (p-value = 0.035).
Economic and financial impact
Activity based costing analysis
From the economic point of view, the implementation
of an Activity Based Costing (ABC) approach was useful
in order to highlight all the costs related to each tech-
nology. As reported in Table 2, the total cost estimated
for the reusable instrument kit was € 4,279.1, while for
the disposable kit it was € 4,242.6 (p-value =0.000).
Cost-Effectiveness analysis
Considering the effectiveness values previously mentioned,
a Cost-Effectiveness Analysis (CEA) was performed: the
two Cost-Effectiveness Values (CEVs) resulted in two indi-
cators equal to 1,202.00 for the reusable kit, and 1,0278.26
for the disposable instruments: the lower the CEV related
to a technology, the more preferable it is in comparison
with the alternatives under investigation.
Budget Impact Analysis
In order to complete the economic and financial dimen-
sion, a Budget Impact Analysis (BIA) was implemented.
The historical scenario, in which all the patients (N = 139)
were treated using the standard reusable instrument kit,
was compared with the innovative scenario, thus consider-
ing 119 procedures performed with the reusable instru-
ment kit and 20 with the innovative disposable one. Over
a 12-month time horizon, the historical scenario required
economic resource absorption equal to € 594,797.68,
whereas the innovative scenario considered a healthcare
expenditure equal to € 594,067.08. The introduction of
the innovative technology into clinical practice would re-
sult in an economic saving equal to −0.12% (−€ 730.60). A
further scenario analysis was performed, comparing the
historical scenario previously mentioned and the best-case
scenario for the innovative technology (thus implementing
it for all the 139 patients undergoing the surgical pro-
cedure): as result, the hospital of reference would decrease
the healthcare expenditure devoted to the treatment of
lumbar arthrodesis by −0.85% (−€ 5,077.67).
It should be noted that for the first year of implementa-
tion of the innovative technology, an additional amount of
€ 224.4 should be added as direct costs needed to ensure
adequate staff training (additional organisational costs).
Even if a budget holder considered the above mentioned
organisational impact of the innovative technology intro-
duction, the final result is positive and in favour of the
innovative technology, thus representing a saving in costs,
ranging from a minimum of −0.09%, in the worst case sce-
nario, to a maximum of −0.82%, in the best case scenario.
Other qualitative dimensions
With regard to the qualitative assessment of the organ-
isational dimension, it emerged that, over a time-horizon
of 12 months (Fig. 1), the introduction of the innovative
technology requires the institutionalisation of specific
training courses devoted to the healthcare professionals
directly involved in the procedure on the one hand. On
the other hand, it positively impacts, on both the in-
ternal and the purchasing processes, thus resulting in a
general quantitative advantage if compared with the
standard one (0.35 vs 0.00, p-value = 0.098).
Over a long-term time horizon (36 months, Fig. 2),
the training could be completed, without requiring any
additional resources. The innovative surgical kit posi-
tively influenced: i) equipment update; ii) equipment
purchase; iii) internal processes, and iv) purchasing
processes, in general. In quantitative terms, the in-
novative kit had a perceived overall organisational




Surgical procedure Human Resources 1,092.5 1,092.5
Laboratory services 115.9 115.9
Consumer product 2,023.2 2,023.2
Drugs 394.5 394.5
Total cost 3,635.14a 3,626.1
Total cost + VAT (17%) 4,253.1 4,242.6
Sterilisation Total cost 21.4 -
Total cost + VAT (20%) 25.7
Total Process 4,279.1 4,242.6
Note: amortisation (a) of the devices must be accounted for during the year
of purchase; thus, in case of reusable instruments, the amortisation is not
considered in the HTA evaluation
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advantage with respect to the traditional one (0.77 vs 0.00,
p-value = 0.003).
The analysis of the legal implications reported that the
two technologies under assessment could be considered
super-imposable in their measurement considering the
indication of use for all the surgical procedures and
for all the categories of patients, and the presence of
authorisations of use.
Figure 3 reported the evaluators’ perception concern-
ing the equity dimension. In particular, the innovative
Fig. 1 Organisational impact (12-month time horizon). Legend Section: The wider the area, the preferable the technology from an organisational
point of view
Fig. 2 Organisational impact (36-month time horizon). Legend Section: The wider the area, the preferable the technology from an organisational
point of view
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technology would lead to a significant decrease in wait-
ing lists, thus improving the access to care in order to
meet the citizens’ health needs. An incremental benefit
related to the innovation resulted from the analysis of
this dimension (0.80 vs 0.00, p-value = 0.011).
With regard to the ethical and social impact, clinicians
declared that the patients could experience a positive
impact from the use of the innovative technology
due to the lower risk of developing future complications,
thus improving the patient’s life style (0.00 vs 1, p-value =
0.007) However, the innovation generates a higher volume
of waste, thus having a negative impact on the environ-
ment and leading to a worse perception on the social
aspects (0.00 vs -0.67, p-value = 0.039).
Detailed results reporting the perceptions regarding
safety, effectiveness, legal, equity, ethical, social and or-
ganisational dimensions are summarised in Table 3.
Appraisal phase
With respect to the last phase of the analysis, both
prioritisation and determination of a final score were
obtained, useful for an evidence-based decision making
appraisal.
In Table 4, the summary of all the results is presented.
With regard to prioritisation, the healthcare professionals
involved in the analysis (N = 5) declared that the most
important dimension was the effectiveness, followed by
economic impact and patient safety.
Three evaluators, different from the ones performing
the prioritisation and the assessment, after a careful ana-
lysis of the results, assigned to each dimension and sub-
dimension a three level mark (equal to 1, 2, or 3), thus
determining the base score, defined as the average value
attributed by the evaluators to each sub-dimension and,
therefore, to each dimension (the sum of the previously
mentioned scores).
After the evaluation of the average score and the total
score, the percentage of incidence of each sub-dimension
was calculated as the average mark assigned by the evalua-
tors, divided by the total possible score for the specific di-
mension. The normalised score was then determined by
multiplying the average base score for the two comparators
with the percentage of incidence.
The final score was obtained by multiplying the nor-
malised score calculated for each dimension with the
normalized value of priority. In this view, the reusable
instrument kit resulted in a score of 0.43, while the
disposable kit resulted in a score of 0.57, underling an
advantage for acquiring the innovative technology.
Discussion
The Activity Based Costing approach showed that the
costs of the two instrument kits are very similar, even
though differences were found in the sterilisation phase
(that must be carried out only in the reusable devices)
and the amortization costs supported for the reusable
Fig. 3 Equity impact. Legend Section: The wider the area, the preferable the technology from an equity point of view
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Table 3 Evaluators’ perceptions
Dimensions Items Reusable Kit Disposable Kit
Safety Adverse events 4 4
Healtcare professionals’ safety 4 4.2
Patients’ safety 4 4.1
Environmental impact 3.95 2.5
Average value 3.99 3.70
Effectiveness Ease to opening the kit 4 4.2
Traceability 4.1 4.1
Surgeon comfort 4.2 3.8
Ease of identification of the product 1.95 4.4
Average value 3.56 4.13
Legal impact Indications of use for all the surgical procedures and
for all the categories of patients
0 0
Presence of national, European and International
authorizations of use
0 0
Average value 0 0





Average value 0 0.80
Ethical impact Acceptability of the technology 0 0
Impact of the technology on the patient life style 0 2
Average value 0 1
Social impact Impact on productivity losses 0 0
Environmental impact 0 −2
Impact of the procedure on the care givers lives and
perceptions
0 0
Average value 0 −0.67
Reusable Kit Disposable Kit Reusable Kit Disposable kit
Short term Short term Long term Long term
Organisational impact Additional staff required 0 0 0 1.25
Staff training 0 −1 0 0
Support staff training 0 1.25 0 0
Patients and care givers training 0 0 0 0
Meetings and communication 0 0 0 0
Learning curve of the staff 0 0.75 0 0
Investment in additional areas 0 1.5 0 1.5
Investment in additional furnitures 0 0 0 1.75
Investment in additional equipment 0 0 0 0.5
Equipment update 0 0 0 0.5
Equipment purchase 0 0 0 1
Impact on the internal processes 0 1 0 2
Impact on the purchasing processes 0 1 0 1.5
Average value 0 0.35 0 0.77
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instrument kit, only considered for the first year of use
of the technology, in line with the Italian administrative
law (that requires the amortization of all the deferred
costs, in the first year). The results from CEA and BIA
highlighted a slight advantage for the innovative technol-
ogy, in terms of CEV and costs savings.
Results reported a residual better performance of the
innovative technology in terms of patients’ safety: this is
amply justified in literature, reporting that a disposable
instrumentation kit could reduce the incidence of surgi-
cal site infections [12], attributing this to a reduction in
exposure to air-borne bacteria in the operating room.
With regard to the organisational impact, the intro-
duction of the disposable instrument kit would lead to
significant advantages in the internal processes in the
operative units and the overall purchasing phase. More-
over, the reduced size of the disposable instrument kit
could guarantee easier management inside the hospital,
both in terms of internal transport and storage processes:
the manufacturing company could ensure supply upon
request, faster than the standard sterilisation process.
In addition, its introduction could lead to a reduction
of waiting lists, due to the quick supply of the devices
(albeit this aspect could be dependent on the agreements





Base score Score Incidence Normalized score Final score
Reusable Disposable MAX (%) Reusable Disposable Reusable Disposable
1 0.222 Effectiveness
(practical research)
2 2 4 100 0.50 0.50
Total 4 0.50 0.50 0.11 0.11
2 0.194 Process analysis 2 2 4 36 0.18 0.18
Economic and
financial impact
CEA 1 2 3 27 0.09 0.18
BIA 2 2 4 36 0.18 0.18
Total 11 0.45 0.55 0.09 0.11
3 0.167 Patient safety 1 2 3 100 0.33 0.67
Total 3 0.33 0.67 0.06 0.11
4 0.139 Quantitative 1 2 3 50 0.17 0.33
Organizational
impact
Qualitative 1 2 3 50 0.17 0.33
Total 6 0.33 0.67 0.05 0.09
5 0.111 Scientific papers
quality
1 1 2 10 0.05 0.05
Description of
the technology
1 2 3 15 0.05 0.10
Description of
the pathology
2 2 4 20 0.10 0.10
General relevance Real and potential
audience




1 2 3 15 0.05 0.10
Potential benefits 2 2 4 20 0.10 0.10
Total 20 0.45 0.55 0.05 0.06
6 0.083 Legal aspects 1 1 2 100 0.50 0.50
Total 2 0.50 0.50 0.04 0.04
7 0.056 Ethical impact 1 2 3 50 0.17 0.33
Social and ethical
impact
Social impact 2 1 3 50 0.33 0.17
Total 6 0.50 0.50 0.03 0.03
8 0.028 Equity 2 2 4 100 0.50 0.50
Total 4 0.50 0.50 0.01 0.01
FINAL SCORE 0.43 0.57
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signed by supplier companies and the hospital of reference)
and their usability.
The present study was proposed for a specific clinical
area (lumbar arthrodesis) in order to overcome the lack
of literature evidence with regard to the investigated
topic. Therefore, the results reported may not be consid-
ered replicable by an external reader, due to the restricted
number of evaluators involved and the small sample of
reference (composed of only 139 patients undergoing the
surgical procedure). The study involved five healthcare
professionals, and all the surgical patients representatives
for this procedure were analysed, thus suggesting com-
pleteness of the results, and allowing their replicability
within all spinal surgery units presenting at least the same
number of patients.
Another limitation of the study is the time horizon taken
into account for the budget impact evaluation that, for a
rapid decision making process, considered only a 12-month
time horizon, This, however, was useful in the negotiation
process with the hospital management board, in accordance
with the hospital budgeting processes and periods [13].
In order to overcome these limitations, an update of
the economic and financial impact is therefore required,
thus considering the healthcare expenditure over a period
of three years.
Conclusions
The present study may be considered as an attempt to
quantify all the implications related to the implementation
of a disposable instrument kit within the specific setting of
lumbar arthrodesis, while not focusing attention only on
argumentations related to the cost-effectiveness trade off.
Despite the lack of evidence in literature, this multi-
dimensional evaluation proved that the two investigated
technologies, albeit apparently super-imposable, present
some differences that needed an in depth analysis.
The HTA approach developed, supported by the MCDA
methodology showed weaknesses and strengths, useful for
both scholars and practitioners. On one hand, the findings
could help scholars to crystalize the urgent need of
effectiveness data among the alternative technologies
under investigation. On the other, practitioners could
understand the reason why they are called to use differ-
ent technologies and to update the surgical practises, even
if they are considered to be safe and consolidated.
In an era of spending reviews and paucity of resources,
all strategies that are able to prevent a higher economic
burden for hospitals and to re-engineer internal pro-
cesses should be evaluated, and then, if affordable and
feasible, implemented.
Abbreviation
ABC: Activity Based Costing Analysis; BIA: Budget Impact Analysis; CEA: Cost-
Effectiveness Analysis; CEV: Cost-Effectiveness Value; HTA: Health Technology
Assessment; MCDA: Multi-Criteria Decision Analysis
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